The membrane-cytoskeleton linker ezrin provides a survival advantage to metastatic osteosarcoma cells that reach in the lung
Year: 2005
Type: article
Source: Cancer Research
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1591868405
